Tetanus nursing: assessment, interventions, prophylaxis, and NCLEX review

Tetanus is a life-threatening neuromuscular disease caused by the toxin of Clostridium tetani — a bacterium whose spores are so widespread in the environment that virtually any break in skin integrity carries theoretical exposure risk. Unlike most infectious diseases encountered in nursing practice, tetanus is not contagious between patients: the threat comes entirely from the wound and the toxin it allows to enter the nervous system. For nursing students, tetanus tests two distinct competency areas simultaneously. The first is pathophysiology recognition — understanding that this is a toxin-mediated disease, not a bacterial invasion, and that the toxin irreversibly binds to nerve terminals before any treatment can reach it. The second is prophylaxis decision-making — knowing precisely which wound types require tetanus immune globulin (TIG), which require vaccine, and which require both, based on the patient’s vaccination history. This reference covers both areas in full, along with the nursing interventions that make the difference between survival and death in active tetanus.

Fast-scan summary: tetanus

Pathophysiology

The organism and its spores

Clostridium tetani is a gram-positive, obligate anaerobe that exists in two forms: a vegetative (active, toxin-producing) form and a highly resistant endospore. The spores are the environmental threat — they survive boiling, many disinfectants, and years in soil without losing viability. Spores are present worldwide in soil, animal feces, dust, and on contaminated surfaces including rusted metal. Essentially any wound that introduces soil or organic debris carries some exposure risk.

The key environmental requirement for spore germination is anaerobic conditions. Spores that enter a wound with adequate oxygen tension do not germinate. In puncture wounds, crush injuries, burns, and necrotic tissue — environments where blood supply and oxygen delivery are compromised — spores germinate into the toxin-producing vegetative form. This explains why the wound characteristics that matter most for prophylaxis decisions are those associated with devitalized tissue and poor oxygenation.

Tetanospasmin: mechanism of action

C. tetani produces two toxins: tetanolysin (minor significance) and tetanospasmin, which is responsible for the entire clinical syndrome of tetanus. Tetanospasmin is a two-chain zinc-dependent metalloprotease — the same class as botulinum toxin — but it produces the opposite clinical effect.

After local toxin production at the wound site, tetanospasmin binds to peripheral motor neuron terminals and undergoes retrograde axonal transport — traveling from the periphery toward the CNS along the interior of motor axons. This is the same mechanism used by the rabies virus (see the rabies nursing reference for comparison), though the cellular targets and clinical outcomes differ dramatically. Once tetanospasmin reaches the spinal cord, it crosses trans-synaptically into inhibitory interneurons.

Within inhibitory interneurons, tetanospasmin cleaves synaptobrevin — a protein required for synaptic vesicle fusion with the presynaptic membrane. Without synaptobrevin, inhibitory neurotransmitter-filled vesicles cannot dock and release their contents. The result is permanent inhibition of inhibitory neurotransmission.

The primary inhibitory neurotransmitters affected are:

• Glycine — released by Renshaw cells in the spinal cord; normally modulates and dampens motor neuron firing
• GABA — the principal inhibitory neurotransmitter at the neuromuscular level in the brainstem

With glycinergic and GABAergic inhibition abolished, motor neurons fire without restraint. Every muscle receiving motor input undergoes sustained, uncontrolled contraction. The clinical result is the rigid spastic paralysis of tetanus.

Tetanus vs. botulism: a critical comparison

Both tetanus toxin and botulinum toxin (BoNT) are zinc-dependent metalloproteases that cleave SNARE complex proteins — but their sites of action and outcomes are opposite:

• Tetanus toxin: acts at inhibitory interneurons in the CNS → blocks inhibitory neurotransmission → spastic (rigid) paralysis
• Botulinum toxin: acts at the neuromuscular junction peripherally → blocks excitatory acetylcholine release → flaccid (limp) paralysis

This distinction is high-yield for NCLEX and clinical recognition. A tetanus patient presents with muscle rigidity and spasm; a botulism patient presents with descending flaccid weakness.

Why natural immunity does not develop

The amount of tetanospasmin required to cause disease is actually below the threshold required to trigger a detectable immune response. Patients who survive tetanus have not produced sufficient antibody to confer immunity — they remain fully susceptible to reinfection. This is one of the most clinically important features of tetanus: recovery does not protect the patient from future exposure, and vaccination must be initiated during or after recovery.

Clinical presentation

Tetanus manifests in four distinct forms, differentiated by the distribution of muscle involvement and the route of infection.

1. Generalized tetanus (~80% of cases)

Generalized tetanus is the most common and most dangerous form. It typically presents with a descending pattern — beginning with muscles supplied by short axons (jaw, face, neck) and progressing downward.

Trismus (lockjaw) is the presenting sign in approximately 75% of cases. It results from masseter muscle spasm and manifests as an inability or difficulty opening the jaw. Patients often report jaw stiffness or difficulty chewing in the early hours before frank lockjaw develops.

Risus sardonicus — the sardonic grin — results from sustained contraction of the facial muscles, particularly the orbicularis oris and zygomaticus. The corners of the mouth are pulled back and upward in a fixed, grimacing expression that persists regardless of the patient’s emotional state. It is pathognomonic for tetanus.

Opisthotonus is the dramatic hyperextension of the back and neck produced by sustained contraction of the paraspinal and neck extensor muscles. The patient arches backward into a rigid bow, with only the heels and head touching the bed. Opisthotonus represents generalized CNS involvement and signals severe disease.

Laryngospasm is the most immediately life-threatening manifestation. Spasm of the laryngeal muscles causes acute airway obstruction — complete in severe cases. This can occur suddenly and without warning at any point in the illness. Nursing vigilance for laryngospasm and immediate airway management capability are the most critical nursing priorities in active tetanus. Tracheostomy is often performed preemptively rather than waiting for acute obstruction.

Reflex spasms are generalized tetanic contractions triggered by external stimuli — noise, light, touch, suction, or even a breeze across the patient’s skin. They are painful, involuntary, and can be severe enough to fracture vertebrae or cause rhabdomyolysis. The nursing implication is critical: the environment must be kept as stimulus-free as possible.

Autonomic instability develops in severe generalized tetanus and represents one of the leading causes of death. Tetanospasmin affects sympathetic and parasympathetic terminals in addition to motor neurons, producing labile blood pressure (hypertensive crises alternating with hypotensive episodes), tachycardia, profuse diaphoresis, and hyperthermia. Cardiac arrhythmias secondary to catecholamine surges are a major cause of mortality in the ICU phase.

2. Localized tetanus

Localized tetanus produces spasm and rigidity confined to the muscle groups surrounding the wound site. Systemic spread does not occur. Prognosis is generally good, though localized tetanus can occasionally progress to the generalized form. It is more common in patients with partial immunity from previous vaccination.

3. Cephalic tetanus

Cephalic tetanus follows wounds to the head or face — including ear infections, facial lacerations, and dental procedures. The short axonal distance to the brainstem means the toxin reaches the CNS rapidly. Clinical features include cranial nerve palsies, most commonly CN VII (facial nerve) palsy, producing facial weakness. Other cranial nerves (III, IV, VI, IX, X, XII) may also be involved. Cephalic tetanus can progress to generalized tetanus and carries a worse prognosis than localized tetanus.

4. Neonatal tetanus (tetanus neonatorum)

Neonatal tetanus occurs in newborns born to mothers with inadequate tetanus immunity. Infection typically enters through the umbilical stump — particularly when nonsterile instruments are used to cut the cord or when traditional cord-care practices introduce contaminated materials. The neonate presents with irritability, poor feeding, and inability to suckle, progressing to trismus, rigidity, and opisthotonus within the first two weeks of life. Mortality ranges from 70–100% without intensive care. Neonatal tetanus is entirely preventable through maternal Tdap vaccination during pregnancy — maternal antibodies cross the placenta and protect the newborn during the vulnerable neonatal period. Neonatal tetanus has been essentially eliminated in countries with high maternal vaccination rates.

Nursing assessment

History and wound evaluation

A thorough history is the foundation of both prophylaxis decisions and clinical recognition. Key questions:

• Wound characteristics: When did the wound occur? What was the mechanism? Was there soil, dirt, feces, or organic material contact? Is the wound a puncture, crush, or avulsion rather than a clean laceration? Was there significant devitalized tissue? Has more than 6 hours elapsed since the wound occurred?
• Vaccination history: How many doses of tetanus-containing vaccine has the patient received, and when was the most recent dose? Has the patient ever received Tdap specifically (not just Td)?
• Symptoms: Has the patient noticed difficulty opening the jaw, neck stiffness, difficulty swallowing, or muscle cramps near the wound site? Even subtle trismus warrants urgent evaluation.

Incubation period and severity correlation

The incubation period — the time from wound exposure to first symptom — averages 8 days but ranges from 3 to 21 days. A critically important clinical principle: shorter incubation predicts more severe disease. A patient with a 3-day incubation from a heavily contaminated wound has more toxin reaching the CNS more rapidly than one with a 14-day incubation. The period of onset (time from first symptom to first reflex spasm) further predicts severity — periods shorter than 48 hours correlate with severe, often fatal disease.

Neurological assessment

• Trismus: Ask the patient to open their mouth fully. Can they fit three fingers (their own) between incisors? Inability suggests early trismus. Jaw rigidity is detectable on examination before frank lockjaw develops.
• Muscle rigidity and spasm: Assess for board-like abdominal rigidity, paraspinal stiffness, neck stiffness, and extremity rigidity. Test for provoked spasms — does tapping the masseter region produce sustained jaw contraction (spatula test)?
• Reflex spasms: Document frequency, duration, and triggers. Note whether spasms are occurring spontaneously or only with stimulation.
• Cranial nerve function: Assess for facial weakness, extraocular movement limitations, and dysphagia.

Respiratory assessment

Airway compromise is the immediate life threat. Assess continuously:

• SpO2 and respiratory rate
• Ability to swallow (aspiration risk is high with dysphagia from pharyngeal spasm)
• Voice quality — hoarseness or stridor suggests laryngeal involvement
• Respiratory pattern — shallow breathing from chest wall rigidity impairs ventilation even before laryngospasm

Autonomic monitoring

In ICU-level care:

• Continuous cardiac monitoring for arrhythmias
• Blood pressure monitoring every 15–30 minutes or via arterial line — look for labile swings (hypertensive crises to hypotensive episodes)
• Temperature monitoring — hyperthermia is common and reflects both sympathetic activation and the metabolic cost of sustained muscle contraction
• Diaphoresis assessment — patients can develop significant fluid and electrolyte losses

Nursing interventions

Airway management — highest priority

The tetanus airway is an emergency waiting to happen. Laryngospasm can occur without warning at any point in the clinical course. Nursing priorities:

• Anticipate early intubation or tracheostomy — do not wait for acute laryngospasm. Elective tracheostomy is standard of care for moderate-to-severe generalized tetanus because awake emergent intubation in a patient with trismus and reflex spasms is extremely difficult and dangerous.
• Keep emergency airway equipment at bedside at all times: bag-valve-mask, suction, laryngoscope, ETT, tracheostomy tray.
• Monitor for stridor, voice changes, SpO2 decline, or abrupt apnea — escalate immediately.
• Suction carefully and minimize duration — suctioning is a potent reflex spasm trigger.

Stimulus minimization — critical nursing environment control

Every nursing action that generates noise, light, or touch risks triggering a painful and potentially fatal reflex spasm. Environmental modifications are not optional comfort measures — they are direct therapeutic interventions:

• Quiet room: close door, post noise restriction signs, coordinate care to minimize traffic
• Dimmed lighting: draw curtains, cover windows, use the lowest functional lighting level
• Cluster care: coordinate all nursing tasks (vital signs, medication administration, wound care, repositioning) into single visits rather than multiple entries — each room entry is a potential spasm trigger
• Gentle touch: warn the patient before any contact; move slowly and deliberately
• Padded side rails: unexpected spasms can throw the patient against hard surfaces
• Limit visitors: family presence is supportive but must be briefed on the stimulus restriction protocol

Wound care and débridement

Wound débridement removes the source of ongoing toxin production — the necrotic anaerobic environment in which C. tetani is actively replicating. However, débridement timing relative to TIG administration is critical:

TIG must be administered BEFORE wound débridement. Surgical manipulation of the wound releases additional toxin into the circulation. If TIG has not yet been given, that toxin surge occurs without circulating antibody to neutralize it. Give TIG → wait for adequate tissue distribution (typically 30–60 minutes) → then perform débridement.

Wound care principles:

• Irrigate wound thoroughly with normal saline or clean water
• Surgically excise devitalized and necrotic tissue — this eliminates the anaerobic microenvironment that sustains C. tetani replication
• Do not pack wound tightly — maintain oxygen exposure to wound bed
• Document wound characteristics using systematic wound assessment principles (see wound assessment guide)

Sedation and muscle relaxation

The goal of pharmacological management is to control spasms without causing respiratory depression severe enough to require mechanical ventilation — though in severe cases, mechanical ventilation is unavoidable.

Benzodiazepines are first-line for spasm control:

• Diazepam: 5–10 mg IV every 3–4 hours; long-acting, accumulates with repeated dosing
• Midazolam: continuous IV infusion preferred in mechanically ventilated patients for titratable sedation
• Mechanism: GABA-A receptor agonists — they potentiate the remaining inhibitory GABAergic tone that tetanospasmin has not fully abolished

Neuromuscular blocking agents (NMBAs) for refractory spasms uncontrolled by benzodiazepines:

• Vecuronium or rocuronium — continuous infusion
• Requires mechanical ventilation — patient cannot breathe independently once paralyzed
• Bispectral index (BIS) monitoring or clinical sedation assessment is essential — a paralyzed patient can be awake and terrified without outward signs

Autonomic instability management

Autonomic dysfunction is a leading cause of death in severe tetanus — often from sudden cardiac arrhythmia. Management requires intensive monitoring and pharmacologic intervention:

• Magnesium sulfate: 3–4 g IV loading dose, then 1–3 g/hour infusion; inhibits catecholamine release from adrenal medulla and nerve terminals; provides mild muscle relaxation; monitor serum magnesium levels, reflexes, respiratory rate, and urine output
• Labetalol: combined alpha and beta blocker; preferred for hypertensive crises because pure beta-blockade is contraindicated (unopposed alpha stimulation worsens hypertension)
• Avoid morphine and other sedatives that depress the sympathetic axis without addressing the catecholamine excess — they can precipitate dangerous hypotension

Seizure precautions

Although tetanic spasms are not true epileptic seizures, the distinction may be clinically difficult, and both can coexist. Standard seizure precautions apply:

• Padded side rails up at all times
• Suction and oxygen at bedside
• Maintain IV access
• Nothing by mouth if swallowing is compromised

Nutritional support

Tetanus patients have massively increased caloric demands from continuous muscle activity, hyperthermia, and diaphoresis. Oral feeding is often impossible due to trismus and dysphagia. Plan for early enteral nutrition via nasogastric or nasojejunal tube. In patients with severe trismus or who are on NMBAs, percutaneous endoscopic gastrostomy (PEG) may be required for prolonged nutrition support. Weigh the patient daily and monitor for ongoing catabolism. For reference laboratory values relevant to nutritional monitoring, see the nursing lab values cheat sheet.

Fall prevention

Sudden, violent tetanic spasms represent an underappreciated fall risk. The spasm can throw a patient from a seated position or cause them to strike a bed rail forcefully. Ensure:

• Bed in lowest position at all times
• Padded full-length side rails
• Non-slip footwear when patient ambulates (recovery phase)
• Call light within reach at all times

Medications

Wound prophylaxis decision tree

The decision to administer TIG and/or tetanus-containing vaccine after a wound depends on two variables: (1) the nature of the wound and (2) the patient’s vaccination history. This decision tree reflects CDC Advisory Committee on Immunization Practices (ACIP) guidelines and is one of the highest-yield topics for NCLEX and clinical practice.

Tetanus-prone wounds include: wounds contaminated with dirt, feces, or saliva; puncture wounds; crush injuries; avulsions; burns; frostbite; wounds with significant devitalized or necrotic tissue; and wounds that are more than 6 hours old before treatment. Any wound that creates an anaerobic environment supports C. tetani germination.

Clean, minor wounds are superficial lacerations with no contamination, no devitalized tissue, and treated promptly.

*Tetanus-prone wounds: contaminated with dirt, feces, or saliva; puncture wounds; crush injuries; avulsions; burns; frostbite; wounds with devitalized tissue; wounds >6 hours old before treatment.

Key clinical principle: For tetanus-prone wounds with unknown or incomplete vaccination history, both TIG and vaccine are given simultaneously but at separate anatomical sites. TIG provides immediate passive immunity (hours); the vaccine initiates active immunity that takes weeks to develop. Neither intervention is redundant — they cover different time windows.

Isolation and transmission

Tetanus is not transmitted from person to person. There is no respiratory, contact, or droplet transmission route for C. tetani or its toxin. Standard precautions are sufficient for all care activities, including wound care.

This is a common point of confusion for nursing students who associate infectious disease with isolation requirements. The distinction is important for patient communication as well — families often fear they will “catch” tetanus from a hospitalized patient. They will not.

Prognosis and recovery

Mortality in developed countries with full ICU access is approximately 10–20% overall. Higher mortality occurs in:

• Elderly patients (immunosenescence, reduced physiologic reserve)
• Neonatal tetanus (70–100% without intensive care; up to 80–90% mortality in resource-limited settings)
• Cases with very short incubation and onset periods
• Cases complicated by aspiration pneumonia, autonomic instability, or prolonged ventilation

Causes of death are respiratory failure (laryngospasm, aspiration, ventilator-associated pneumonia from prolonged intubation, chest wall rigidity impairing ventilation) and autonomic instability (sudden cardiac death from catecholamine-induced arrhythmia).

Recovery timeline is prolonged. Because tetanospasmin binds irreversibly to nerve terminals, clinical improvement does not occur until new nerve terminal growth restores normal synaptic function — a process that takes weeks to months. Patients with severe tetanus frequently require 4–8 weeks of mechanical ventilation. Full functional recovery is possible with aggressive supportive care.

Post-recovery immunity: As noted above, surviving tetanus does not confer immunity. The tetanus toxoid vaccination series must be initiated during the recovery period. Clinically, this is a unique situation in infectious disease — most infections confer at least partial protective immunity. Tetanus does not, and patient and family education on this point is essential to prevent recurrence.

If wound infection progresses to systemic involvement, the nurse should also monitor for early sepsis indicators, as secondary bacterial infection of tetanus wounds can trigger a systemic inflammatory response. See the sepsis nursing reference for sepsis recognition and bundle care.

Prevention and vaccination

The DTaP and Tdap vaccines have made tetanus rare in vaccinated populations. Understanding the vaccination schedule is essential for both prophylaxis decisions at the bedside and patient education.

Childhood DTaP series (diphtheria, tetanus, acellular pertussis):

• 5-dose series: 2 months, 4 months, 6 months, 15–18 months, 4–6 years
• Completion of this series provides the baseline immunity that adult booster schedules depend upon

Tdap booster (lower-dose tetanus and diphtheria toxoid, acellular pertussis):

• Adolescents: single dose at 11–12 years
• Adults who have never received Tdap: single dose (replacing one Td booster)
• Pregnant women: one dose during each pregnancy at 27–36 weeks gestation (to maximize transplacental antibody transfer to the newborn)

Td booster (tetanus and diphtheria toxoid, no pertussis):

• Adults who have completed the primary series and received Tdap: Td every 10 years
• Can be given earlier if patient has a tetanus-prone wound and last dose was more than 5 years ago

Neonatal tetanus prevention is achieved almost entirely through maternal vaccination. Tdap given during pregnancy generates maternal antibodies that cross the placenta in the third trimester, protecting the neonate before their own immune system is mature enough to respond to vaccine.

NCLEX practice questions

Summary: nursing priorities in tetanus

Tetanus nursing care operates on two tracks simultaneously. In the acute phase, the priority order is: secure and protect the airway → minimize environmental stimuli to reduce reflex spasms → administer TIG before débridement → control spasms pharmacologically → address autonomic instability → provide aggressive nutritional and supportive care. In the prophylaxis setting, the priority is accurate vaccination history assessment followed by correct application of the wound prophylaxis decision tree — a skill that prevents the disease before it starts.

The clinical uniqueness of tetanus — a toxin-mediated, non-contagious disease where treatment cannot reverse bound toxin, where recovery does not produce immunity, and where a properly maintained vaccination card would have prevented everything — makes it one of the most instructive cases in all of nursing education. Understanding tetanus deeply means understanding both the limits of what medicine can do (we cannot unbind the toxin) and the power of what prevention can do (a $20 vaccine eliminates the risk entirely).

References: CDC. (2024). Tetanus — for clinicians. Centers for Disease Control and Prevention. | CDC/ACIP. (2023). Preventing tetanus, diphtheria, and pertussis: recommendations for adult vaccination. MMWR. | Thwaites CL, Beeching NJ, Newton CR. (2015). Maternal and neonatal tetanus. Lancet, 385(9965):362–370. | Cook TM, Protheroe RT, Handel JM. (2001). Tetanus: a review of the literature. British Journal of Anaesthesia, 87(3):477–487. | Farrar JJ, et al. (2000). Tetanus. Journal of Neurology, Neurosurgery & Psychiatry, 69(3):292–301.